back to indexEssentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson

Chapters
0:0 Matthew Johnson; Psychedelics
1:44 Different Classes of Psychedelics
4:33 Psychedelics & Altering Models
6:18 LSD, Psylocibin & Serotonin
8:44 Psychedelic Clinical Trials
12:28 Therapy, Trust, Psychedelics
15:36 Letting Go & Psychedelic Experience, Self-Representation, Lasting Changes
21:19 MDMA, Dopamine & Serotonin; Bad Trips & Transcendental Experience
24:43 Dangers of Psychedelics
27:4 Microdosing Psychedelics, Antidepressant
31:20 Head Injuries, Psychedelics, Depression
00:00:00.000 |
Welcome to Huberman Lab Essentials, where we revisit past episodes for the most potent and 00:00:05.400 |
actionable science-based tools for mental health, physical health, and performance. 00:00:10.000 |
I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford 00:00:15.980 |
School of Medicine. And now, my conversation with Dr. Matthew Johnson. Well, Matthew, 00:00:21.000 |
I've been looking forward to this for a long time. I'm a huge fan of your scientific work, 00:00:26.300 |
and I'm eager to learn from you. Likewise. Big fan and happy to do this with you. 00:00:31.420 |
All right. Well, thank you. My first question is a very basic one, which is what qualifies a substance 00:00:37.480 |
as a psychedelic? Nomenclature is a real challenge in this area of psychedelics. So, starting with the 00:00:45.420 |
word psychedelic, it just, if you're a pharmacologist, it's not very satisfying because that term really 00:00:54.240 |
spans different pharmacological classes. In other words, if you're really concerned about receptor 00:00:59.500 |
effects and the basic effects of a compound, it spans several classes of compounds. But overall, 00:01:07.600 |
so it's really more of a cultural term or it does have a relationship to drug effects, but it's at the 00:01:17.280 |
at a very high level. So, all of the so-called psychedelics across these distinct classes that I 00:01:25.260 |
can talk more about, the way I put it is they all have the ability to profoundly alter one's sense of 00:01:33.260 |
reality. And that can mean many things. Part of that is profoundly altering the sense of self 00:01:38.380 |
acutely. So, when someone's on the psychedelic. So, the different classes that can be the specific 00:01:47.760 |
pharmacological classes that can be called a psychedelic are one that what are called the 00:01:53.720 |
classic psychedelics. So, in the literature, you'll see that term. And hallucinogen and psychedelic are all 00:02:00.020 |
have traditionally been used synonymously. I think there was a little of a tendency to stay away from 00:02:05.940 |
psychedelics of the baggage, but there's been a return to that in the last several years. But the 00:02:10.900 |
classic psychedelics or classic hallucinogens are things like LSD, psilocybin, which is in so-called 00:02:19.300 |
magic mushrooms. It's in over 200 species that we know of so far of mushrooms. Dimethyltryptamine or DMT, 00:02:27.540 |
which is in dozens and dozens of plants. Mescaline, which is in the peyote cacti and some other cacti like 00:02:35.940 |
San Pedro. And even amongst these classic psychedelics, there are two structural classes. So, that's the 00:02:45.060 |
chemistry. There's the tryptamine based compounds like psilocybin and DMT. And then there's the 00:02:50.980 |
phenethylamine based compounds. So, these are the basic two basically building blocks that you're 00:02:57.380 |
starting from, either a tryptamine structure or a phenethylamine structure. But that's just the 00:03:02.500 |
chemistry. All of the, what's more important, or at least to someone like me, are the receptor effects. 00:03:09.700 |
And then ultimately, that's going to have a relationship to the behavioral and subjective 00:03:13.380 |
effects. So, all of these classic psychedelics serve as agonists or partial agonists at the 00:03:18.660 |
serotonin-2A receptor. So, subtype of serotonin receptor. Then you have these other classes of 00:03:25.860 |
that you, compounds that you could call psychedelic. Another big one would be the NMDA antagonists. So, 00:03:33.060 |
this would include ketamine, PCP, and dextromethorphan, something I've done some research 00:03:38.340 |
with which folks might recognize from like robo-tripping, guzzling like, you know, call syrup. 00:03:44.900 |
A large overlap in the types of subjective effects that you get from those compounds compared to the 00:03:50.420 |
2A agonist classic psychedelics. But then you have another big one of MDMA, which really stands in a 00:03:57.620 |
class by itself. So, it's been called an intactogen. What does that mean? It means like touching within. 00:04:05.460 |
It sort of eludes to the idea that it can really put someone in touch with their emotions. It's also 00:04:12.020 |
been called an empathogen, meaning it can afford empathy. So, I get the impression that 00:04:18.020 |
the psychedelic space is an enormous cloud of partially overlapping compounds. 00:04:23.540 |
Meaning, some are impacting the serotonin system more than the dopamine system. Others are 00:04:28.820 |
impacting the dopamine system more than the serotonin system. 00:04:31.860 |
Given that the definition of a psychedelic is that it profoundly alters sense of self, 00:04:38.100 |
at least that's included as a partial definition. 00:04:42.260 |
Mm-hmm. I think of psychedelics as profoundly altering models. You know, we're prediction machines, 00:04:52.100 |
and so much of that is top-down. And psychedelics have a good way of, loosely speaking, dissolving those 00:05:07.060 |
Can you give us an example of a model? Like, I know that when 00:05:11.460 |
I throw a ball in the air, it falls down, not up. 00:05:14.100 |
This might sound extreme, but there are these cases. It was overblown in sort of the propaganda 00:05:19.300 |
of the late '60s, early '70s, but there are credible cases of people, and it's very atypical, of 00:05:25.860 |
sounds like they really thought they could fly and, you know, jump out of a window. Now, 00:05:33.060 |
far more people every year fall, I mean, who knows, you know, they fall and die out of, you know, 00:05:41.140 |
from height because they're drunk, you know. So, this is extremely rare. But, you know, 00:05:46.340 |
there are some, like, pretty convincing cases. There was one research volunteer in our studies 00:05:52.180 |
that she looked like she was, in one of our studies, like, she was trying to dive through 00:05:59.780 |
a painting on the wall. She was fine, but she, reviewing the video, it looked like 00:06:06.660 |
she really thought that she was going to go through that painting, and who knows? 00:06:14.900 |
- Yeah. So, they're violating these predictions. The reason I ask it, the question the way I did, 00:06:19.860 |
is because given the enormous cloud of different substances, and given the range of 00:06:24.660 |
previous experiences that people show up to a psychedelic experience with, 00:06:29.140 |
I feel like the ability to extract some universal themes is useful, especially for people who haven't 00:06:37.540 |
- Who might not have an understanding of what their effects are like. Can we just briefly touch on 00:06:46.980 |
- So, compounds like LSD, lysergic acid, diethylamide, and psilocybin, my understanding is that they 00:06:55.300 |
primarily target the serotonin system. How do they do that at a, kind of, general level? And why would 00:07:05.460 |
increasing the activity of a particular serotonin receptor, or batch of serotonin receptors, lead to 00:07:11.060 |
these profoundly different experiences that we're calling model challenges, challenging pre-existing 00:07:20.500 |
- I mean, at the end of the day, it's a chemical, and these receptors are scattered around the brain with 00:07:27.780 |
- What do we think is going on in a general sense? 00:07:32.740 |
- Yeah. Yeah. And this is really the area of active exploration, and we don't have great answers. We know 00:07:39.140 |
a good amount about the receptor-level pharmacology. Some things about post-receptor signaling pathways. 00:07:45.220 |
In other words, just fitting into the receptor. Clearly, you know, serotonin itself is not 00:07:50.580 |
psychedelic, you know, or else we'd be tripping all of us all the time. 00:07:53.780 |
- Because when I eat a bagel, I get serotonin release, right? - Uh-huh. 00:07:56.820 |
- I mean, there's— - And it's very different than LSD. 00:07:58.580 |
- Or turkey. I mean, there's triptophan, right. - Mm-hmm. 00:08:00.660 |
- My understanding of serotonin is that in very broad strokes, that it generally leads to a state of being 00:08:07.620 |
fairly—it pushes the mind and body towards a state of contentment within the immediate experience. 00:08:14.980 |
Whereas the dopamine system really places us into an external view of what's out there in the world 00:08:22.020 |
- Is that fair to say? - Need to do something. 00:08:23.700 |
I mean, that's consistent with my understanding. 00:08:26.740 |
And I'll certainly not in terms of—I don't primarily identify as a neuroscientist. 00:08:32.980 |
I'll definitely tell the, you know, the viewers that we're far more in your domain here than mine, 00:08:38.580 |
but in terms of how psychedelics and other drugs, you know, interface at the neuroscience level. 00:08:43.700 |
- Well, feel free to explain it at the experiential level. 00:08:46.660 |
- Yeah. - I mean, it doesn't have—let's say I were to come to one of your clinical trials, 00:08:50.820 |
because these are clinical trials, right, at your lab at Hopkins. 00:08:56.340 |
or could I just be somebody who wanted to explore psychedelics? 00:08:59.220 |
- We've had studies for all of these. - Okay. 00:09:03.700 |
So healthy normal studies—the code for not a problem to fix, but we're all— 00:09:08.340 |
that's what's amazing about psychedelics, though, because if you administer them under this model, 00:09:13.700 |
and you develop a relationship and give a high dose of psychedelic, 00:09:16.500 |
you can be a healthy normal without a diagnosable issue, but, man, we're all human, 00:09:21.060 |
and the issues seem to come to the surface. - Sure, yeah. 00:09:23.620 |
- So, but we've done work with smoking cessation, so people trying to quit tobacco and haven't been successful. 00:09:30.820 |
- So, maybe I'll just ask some very simple questions that would kind of step us through the process. 00:09:35.060 |
So, let's say I were to sign up for one of these trials, and I qualified for one of these trials. 00:09:39.620 |
I'd show up—you said I would do several hours in advance of getting to know the team that would, 00:09:43.860 |
that would be present during this psychedelic journey. 00:09:47.620 |
- First, there's screening, so it's kind of like a couple of days of both psychiatric, 00:09:52.020 |
like structured psychiatric interviews about your whole, your past, and symptoms across the 00:09:58.260 |
the DSM, the psychiatric bible, to see if you might have various disorders that could disqualify you, 00:10:04.900 |
like the main ones being the psychotic disorders, schizophrenia, and also including 00:10:09.940 |
bipolar, so the manic side of bipolar. So, so after that, and also cardiovascular screening, 00:10:16.020 |
heart disease, after that screening, then the preparation where you get, you're both, 00:10:19.940 |
you get, you develop a therapeutic rapport with the people who are going to be in the room with you, 00:10:24.740 |
your guides, but you're also then didactically sort of explained about what the psychedelic could be 00:10:32.100 |
like, and that's kind of a laundry list because they're more known by their variability. 00:10:37.380 |
You could have the most beautiful experience of your life, or the most terrifying experience of 00:10:42.500 |
your life. So it's this kind of laundry list of like the things that could happen, so there's 00:10:46.900 |
- I think it's so important for people to hear because you really can't predict how somebody is going to 00:10:52.340 |
react internally. Let's say that somebody passes all the prerequisites, and it's the day. 00:11:00.180 |
Comes the day that they're going to have this experience. Are they eating mushrooms like you 00:11:07.300 |
hear about, or are they taking it in capsule form, and how do they get it into their body? 00:11:11.460 |
- So they receive pure psilocybin. Most of our studies are looking at where we want a psychedelic 00:11:18.020 |
effect are in the 20 to 30 milligram range. The session day itself is not full of, for most of our studies, 00:11:25.540 |
is not full of tasks. We really want to look at the therapeutic response. Obviously, if it's a 00:11:30.020 |
therapeutic study, we want it to be a meaningful experience. And research has found, not surprisingly, 00:11:36.100 |
that you get a less meaningful experience when you're in an fMRI, or when you're doing a lot of 00:11:41.620 |
cognitive tasks. So our typical therapeutic model, which again, isn't just limited necessarily to the 00:11:47.380 |
therapeutic studies where we're trying to treat a specific disorder, is to have that preparation. 00:11:54.020 |
So the person feels very comfortable with their guides. I mean, ultimately, what I tell people is 00:12:00.740 |
like, any emotional response, it's all welcome. I mean, you could be crying like a baby hysterically, 00:12:09.220 |
like that's what you should be doing if that's what you feel like. 00:12:11.780 |
- I mean, you're doing therapy for people. This is, it's not just about the experience. 00:12:15.940 |
- Right. And the experience itself is very much shaped by that container, by the environment, 00:12:22.420 |
and the degree to which one allows it to happen. Like one should let go of control. 00:12:27.780 |
- The letting go of control is an interesting feature, actually, because one of the common 00:12:32.420 |
themes of good psychoanalysis or psychotherapy of any kind is that there's a trust built between 00:12:38.500 |
the patient and the analyst and that relationship becomes a template for trust more generally and 00:12:45.540 |
trust in oneself. How do you convince people to go further and further down that path? What do you 00:12:51.460 |
think allows them to do that? Because I think that that to me is one of the more unusual aspects to 00:12:57.780 |
psychedelics is that normally the, the social pressure, but also just our internal pressure 00:13:04.020 |
from our own brain is pay attention to many things at once, not just one. Is that- 00:13:12.340 |
- Multi-task. And the more that we focus on one thing, the more bizarre that thing actually can appear to 00:13:19.300 |
- I mean, even if it's the tip of your finger and you're not taking any psychedelics, you spend a long 00:13:22.740 |
enough looking at the tip of your finger, you will notice some very weird things, right? 00:13:27.140 |
- That's, I think of that as the classic psychedelic effect or one classic effect and one I've used many 00:13:32.980 |
times of this example of why people shouldn't necessarily, you know, these aren't, these, 00:13:40.340 |
one should be judicious in putting themselves in these circumstances. Someone could be, you know, 00:13:46.420 |
having a very strong psilocybin experience and they're trying to navigate their way in 00:13:51.460 |
Manhattan crossing the street and they might be staring into the hand and real like that's, 00:13:56.740 |
their hand is the most amazing miracle. Like the entire universe has essentially conspired to come 00:14:02.740 |
to this one point to make this absolutely breathtaking. It's almost like, I think of the simplest form of, 00:14:08.660 |
of, of what we know, the simplest form of learning is habituation. Simply keep applying stimuli and there's 00:14:13.780 |
less response. Like, this is what organisms do. This is what we have to do. And it's like, 00:14:17.940 |
there's this dis habituation component that like- 00:14:21.780 |
- Yes. Like we wouldn't be able to get through life if we wouldn't be able to cross that street, 00:14:25.380 |
if we were like, hold, like this is a miracle. 00:14:28.580 |
- It sounds like on psychedelics, the, one of the primary goals therapeutically is to really drill into one of 00:14:34.260 |
these perceptual bubbles and expand that bubble and the safety it seems is the safety. It's sort of like 00:14:41.300 |
a permission to, to do that without worrying that something's going to happen. 00:14:46.420 |
- Right. Because, you know, I've had people there on the couch. 00:14:50.980 |
Yeah. I remember one lady said, this is probably, uh, 13, 14 years ago said, 00:14:56.180 |
"Matt, tell me again. I can't die. Like, I feel like my heart is going to rip through my chest." 00:15:01.620 |
I mean, she was feeling her, and I should say, typically cardiovascular response is, is modest. 00:15:07.300 |
The, the pulse and blood pressure go up. And if it goes over a certain level, we have a protocol and 00:15:12.420 |
we've had to do this only a few times, but the physician comes in, gives them a little nitroglycerin 00:15:16.580 |
under the tongue, uh, and, uh, you know, knocks the blood pressure down a little bit, 00:15:19.860 |
doesn't affect the experience. So we have it all in place, even though they'd probably be fine out of 00:15:23.700 |
an abundance of caution. Um, but, but yeah, but someone can feel that, my God, I'm going to die. 00:15:31.300 |
Like I, I have never felt my heart beat like this before. 00:15:36.260 |
So there's a, an expansion of a particular, fairly narrow percept. It could be sound, 00:15:42.340 |
could be an emotion, could be sadness, could be a historical event or a fear of the future. 00:15:47.380 |
And you've mentioned before that there's something to be learned in that experience. 00:15:54.180 |
There's something about going into that experience in a, in an, um, in an, in an undeterred way 00:16:02.580 |
that allows somebody to bring something back into more standard reality. 00:16:08.740 |
Given the huge variety of experiences that people have on psychedelics, given the huge variety of 00:16:13.940 |
humans that are out there, but what are now very clear therapeutic effects in the realm of depression, 00:16:20.900 |
what do you think is the value of going into this fairly restricted perceptual bubble? What we are 00:16:28.900 |
calling letting go or giving up control, because if the experiences are many, but the value of what 00:16:36.420 |
one exports from that experience is kind of similar across individuals, that raises all sorts of 00:16:42.340 |
interesting questions. And this is not a philosophy discussion. We're talking about biology and 00:16:49.460 |
This is in the terrain we're figuring out, you know, so there's no, the educated speculations, 00:16:55.140 |
the best I can provide, but I, I think the best, the, the, the, the most, I think the common denominator 00:17:04.100 |
are persisting changes in self-representation. 00:17:08.900 |
Okay. Tell me more about self-representation. 00:17:11.140 |
That's, uh, the way one holds the sense of self, the relate, the fundamental relationship 00:17:18.580 |
of a person in the world. I mentioned earlier that these experiences seem to alter the models we hold 00:17:24.820 |
of reality. And I think that the self is the biggest model that I am a thing that's separate from other 00:17:29.860 |
things. And that's, I am defined by certain, I have a certain personality and I, I'm a smoker that's 00:17:37.460 |
having a hard time quitting, or I'm a depressed person that, you know, views myself as a failure and all of 00:17:43.220 |
these things. Those are models too. So this is this expansion of the perceptual bubble, a narrow, 00:17:48.820 |
a narrow, uh, percept that then grows within the confines of that narrow percept. 00:17:54.980 |
The, so sense of self is a very interesting, uh, phenomenon. And if we could dissect it a little 00:18:00.180 |
bit, um, there's the somatic sense of self. So the ability to literally feel the self, uh, 00:18:06.260 |
into this process we call interoception. And then there's the, the, the title of the self, 00:18:11.140 |
the I am blank. Yeah. And I noticed you said that several times and it's intriguing to me how one 00:18:16.340 |
defines themselves internally, not just to other people, but how one psychologically and by default 00:18:25.700 |
in, uh, defines themselves, I think is very powerful. Like, um, and depressed people as well as happy 00:18:32.020 |
people seem to define themselves in terms of these categories of emotional states. So I think it's, 00:18:36.980 |
it's so interesting that letting go and going into this perceptual bubble, which is facilitated by 00:18:44.500 |
obviously a really wonderful team of, of therapists, but also the serotonergic agent allows us to, um, 00:18:51.460 |
potentially reshape the perception of self. That's, that's a tremendous feat of neuroplasticity. 00:18:57.780 |
Right. I think there's something about this change in, in sense of self. There is, it seems to be 00:19:02.660 |
something on the identity level, both with, I think of the, the work we did with cancer patients who had 00:19:07.060 |
substantial depression and anxiety because of their cancer, and also our work with people trying to quit 00:19:11.940 |
cigarette smoking. I mean, there's this real, there seems to be when it really works, this change in how 00:19:19.700 |
people view themselves like smoking, like really stepping out of this model. Like I'm a smoker. 00:19:29.140 |
It's tough to quit smoking cigarettes. I can't do it. I failed a bunch of times. I remember one 00:19:34.980 |
participant during the session, but he held onto this afterwards said, my God, it's like, I can really 00:19:40.980 |
just decide like flicking off a bike. I can decide not to smoke. And it's, I call these duh experiences 00:19:47.380 |
with psychedelics because people often like in the cancer studies say, I'm causing most of my own 00:19:53.060 |
suffering. Like I can, I can follow my appointments. I can do everything, but I can still plan for the, 00:19:57.860 |
I'm not getting outside in the sunshine. I'm not playing with my grandkids. I'm choosing to do that. 00:20:03.540 |
And it's like, they told themselves that before. And the smoker has told themselves a million times 00:20:08.020 |
I can, so it sounds when it comes out of their mouths and folks will say, this is part of the 00:20:13.460 |
ineffability of a psychedelic experience. Folks say, I know this sounds like bullshit. And this sounds like, 00:20:18.180 |
but my God, I could just decide. Like they're feeling this gravity of agency that seems to be at times 00:20:26.980 |
fundamentally like supercharged from a psychedelic experience. This idea, like I'm just going to make 00:20:32.980 |
make a decision. Like normally, like you tell a depressed person, like, don't, 00:20:37.140 |
don't think of yourself that way. You're not a failure. You're looking at all that. It's just, 00:20:40.180 |
yeah. It's like, and you can actually, in one of these states have an experience where you realize 00:20:44.820 |
like, my God, just like using MDMA to treat PTSD. And we're going to be starting work with psilocybin 00:20:50.020 |
to treat PTSD. Someone could really reprocess their trauma in a way that like has lasting effects. 00:20:57.700 |
And clearly there's probably something, you know, reconsolidation of those memories. They are, 00:21:01.620 |
they are, they are altered, you know, very consistent with what the, our understanding of the 00:21:07.460 |
way memory works. So the whole idea of people can actually, in a few hours, have a, such a profound 00:21:13.860 |
experience that they, they decide to make these changes in who they are and it sticks. 00:21:19.780 |
I'm fascinated by this idea that a, a somatic and a perceptual experience, but a real experience of 00:21:27.220 |
the sort that you're describing is what allows us to reshape our neural circuitry and to feel 00:21:32.100 |
differently about ourselves. And I know there's been really tremendous success in many individuals of 00:21:40.180 |
alleviating depression, of treating trauma with these different compounds. If we could, 00:21:46.020 |
I'd like to just ask about some of the more dopaminergic compounds, in particular MDMA. 00:21:51.060 |
Yeah. And my understanding is that MDMA leads to very robust increases in both dopamine and serotonin 00:21:59.700 |
simultaneously. So why would it be that having this increased dopamine and increased serotonin would 00:22:08.020 |
provide an experience that is beneficial? And how do you, to the extent that you can describe it, 00:22:15.060 |
how do you think that experience differs from the sorts of experiences that people have on psilocybin 00:22:19.620 |
or more serotonergic agents? Speculating, but it may be that MDMA for a broader number of people 00:22:27.940 |
is better for, for trauma because the chances of having an extremely challenging experience, what I call 00:22:35.780 |
the bad trip, like really freaking out is much lower with MDMA. People can have bad trips, but they're of a 00:22:43.380 |
different nature. It's not, it's not sort of like freaking out because all of reality is sort of 00:22:49.540 |
shattering and it's less of this. It can take so many forms with the classic psychedelics, but like 00:22:56.180 |
typically you'll, you'll hear something like, I didn't know it was going to be like this, no matter how 00:23:02.500 |
hard you tried to prepare them that like, this is like, get me off this. You're talking about LSD or 00:23:09.220 |
psilocybin. Yeah. Yeah. And just the sense of like, I'm going insane. This is so far beyond anything I've 00:23:18.260 |
ever experienced. And it's scaring the out of me. I don't have a toehold on anything, even that I exist 00:23:26.580 |
as, as, as, as an entity. And that can be really, I think, frankly, experientially, that's kind of the 00:23:32.420 |
gateway to both the transcendental mystical experiences, the, the, the sense, uh, of unity 00:23:39.540 |
with all things, which we know our data suggests is related, um, to long-term positive outcomes. 00:23:46.260 |
Wait, I want to make sure I understand. So you're saying the bad trip can be related to the 00:23:49.780 |
transcendental experience. Right. I think those are both speculating, but you, you have to pass through 00:23:56.020 |
this sort of like, you know, reality shattering, including your sense of self. And one can handle 00:24:02.660 |
that in one of two ways. You can either completely surrender to it, or you can try to hang on. And if 00:24:09.380 |
you try to hang on, it's going to be more like a bad trip. So again, I wish there was more, and hopefully 00:24:13.780 |
there will be more experimentation. There's a lot going on here in the black box in terms of the operant 00:24:19.220 |
behavior of how you are, you know, within yourself choosing to handle like letting go, you know, 00:24:26.420 |
and eventually we'll be able to see this in real time with brain imaging. Ah, there they are surrendering 00:24:31.540 |
to the psychedelic experience here. They are trying to hold on, but we we're not there yet. But I think 00:24:37.460 |
it's a good through clinical observation seems pretty clear that something like that is going on. 00:24:42.580 |
There has been an attempt at creating this movement toward openness about psychedelics and their positive 00:24:50.020 |
effects. This has happened before. The difference is that now there are people like you inside the walls 00:24:55.380 |
of the university or publishing peer reviewed studies and things of that sort. The question is to me, 00:25:00.660 |
you know, what are the, what are the valuable exports, right? And where does the extreme lie? I mean, 00:25:06.580 |
clearly there's a, there's a problem with tinkering with reality through pharmacology and there's a 00:25:14.980 |
benefit. It sounds like to tinkering with reality through pharmacology and for the average person, 00:25:22.900 |
right? Or for kids that are hearing this kids that are in their teens, right? Yeah. What are the, 00:25:27.940 |
I want to talk about what are the dangers of psychedelics? This is something you don't hear a lot 00:25:32.100 |
about these days and it's not because I'm anti-psychotic at all, but what are the dangers? 00:25:36.660 |
Yeah. So these can be profoundly destabilizing experiences and ones that, you know, ideally 00:25:45.860 |
are had in a safe container, you know, sort of where, where someone, you know, 00:25:54.660 |
what are the relevant dangers and what can we do to mitigate those? So there's two biggies. 00:26:00.660 |
One, and I've already mentioned, it's people with very severe psychiatric illness, not, not depression, 00:26:09.860 |
not anxiety. I'm talking about psychotic disorders like schizophrenia or mania as part of bipolar disorder. 00:26:21.220 |
Anyone can have this, the most psychologically healthy person in the world, probably. 00:26:25.540 |
You jack the dose high enough and especially in, in, in a less than an ideal environment, 00:26:31.540 |
you can have a bad trip. You can, you even get it in an ideal environment like ours at, 00:26:36.020 |
at a high dose of around 30 milligrams of psilocybin. After, you know, the best preparation we can provide, 00:26:42.340 |
about a third of people will say, essentially at some point they have a bad trip, you know, and we. 00:26:47.460 |
At some point within the entire journey. Right. Now they could have one of the most beautiful 00:26:52.260 |
experiences of their life, sometimes like a couple minutes later. Right. But at some point they had a 00:26:57.220 |
sense of strong anxiety, fear, losing their mind, feeling trapped, something like that. 00:27:03.780 |
I definitely want to ask you about micro dose versus standard or macro dosing psilocybin. 00:27:10.500 |
I'm micro cynical, if you will, about this term micro dose. Is there any clinical evidence or peer 00:27:17.140 |
reviewed published evidence that it works, quote unquote, to make people feel better about anything? 00:27:22.340 |
So yeah, the claims are in their number of them. There's two general ones. One is, is sort of acting 00:27:29.460 |
in place of the ADHD treating drugs. So the psychomotor stimulants, so like a better version of Adderall. 00:27:36.740 |
The other claims are essentially a better version of, of the traditional antidepressants, 00:27:42.820 |
a better version of Prozac. None of the peer reviewed studies that are, have much credibility. 00:27:48.900 |
Um, none of them have shown a benefit. The handful of studies that have done that have shown 00:27:56.340 |
they've ranged from finding no effect whatsoever to just a little bit of impairment, like impairing 00:28:02.420 |
someone's ability to do, um, time estimation and production tasks. So you want an accurate sense of 00:28:08.420 |
time, at least if you're navigating in the real world, it's different if you're on the couch on 00:28:12.820 |
a heroic dose for therapeutic reasons where you're safe. But if you're crossing the street, 00:28:17.460 |
if you're getting, you know, in your work life, which is what the way people are claiming to, you know, 00:28:22.660 |
use that it helps them be a better CEO. Like you want an accurate sense of time. So if anything, 00:28:27.860 |
the data suggests that it makes it a little bit less accurate. And, and there's evidence that someone 00:28:33.460 |
feels, uh, a little bit impaired, um, and they feel a little bit high. So in terms of, you know, 00:28:40.580 |
you call that abuse liability and research so far, no studies have, have shown, you know, 00:28:46.980 |
any increase in creativity, enhancement of any form of cognition or, or, or a sustained improvement in mood. 00:28:55.940 |
Now, no studies have actually looked at the, the, the, the system of microdosing that the 00:29:03.380 |
aficionados are claiming folks like, um, Paul Stamets and others, they'll have particular formulas. 00:29:09.220 |
They're like, you need to take it one day and then take so many days off and take it every four days. 00:29:14.100 |
And they really say, you need to be on it for a while. Like a few weeks in, you may start to notice 00:29:18.340 |
through this pattern of, of, of using it. And you, you're, you're feeling the benefits 00:29:22.900 |
on those off days, like the three or two days in between your active doses. So those are the claims. 00:29:30.100 |
Again, we don't know that there's any truth to that working, but studies have not been done 00:29:34.500 |
to model that. So that's a big caveat. My bet is, and this is totally based on anecdotes that I think 00:29:42.580 |
there is probably a reality to the antidepressant effects. I find that more intriguing because of 00:29:48.180 |
the suffering with depression, right? Even if it's an, it, it wouldn't be as interesting as I think 00:29:53.140 |
what we're doing with high dose psilocybin or psychedelics to treat, um, depression. It would 00:29:58.580 |
be, if this is developed and there's a reality, it would be more like a better, you know, perhaps a 00:30:03.780 |
better SSRI, a better Prozac, which are similar, more tools than fewer tools in the toolbox. And it 00:30:11.220 |
shouldn't be that surprised. Like even before the, as going back to the tricyclics and the MAO 00:30:17.140 |
inhibitors going back to the fifties, like augmenting extracellular serotonin in one way or another 00:30:23.140 |
for many people leads to a, to reduction in depressive symptoms. It wouldn't be that crazy 00:30:29.460 |
for chronically stimulating a subtype of serotonin receptor that you have an antidepressant effect. 00:30:35.380 |
So I think if I had put my bets on it, that there's, if there's anything real, it is in that category. 00:30:40.980 |
Although I'm very open to like, maybe there is something to the creativity, 00:30:43.940 |
to the, you know, improved cognition, which covers many domains in and of itself. But, um, my, my 00:30:52.820 |
greatest hopes are on the, uh, on the antidepressant effects that said in the big picture, I think all of 00:30:59.700 |
the most interesting thing about psychedelics are the heroic doses. I mean, the idea that you can give 00:31:04.020 |
something one, two, three times and you see improvements in depression months later and in 00:31:09.700 |
addiction, you know, over a year later and with these, you know, people dealing with potentially 00:31:15.540 |
terminal illness. I mean, it's, I mean, I'm interested in big effects. 00:31:19.860 |
Right. I want to make sure that I ask you about the other really important mission that you're 00:31:24.340 |
involved in with respect to psychedelics, which is not about depression per se, but is about 00:31:29.700 |
neurological, a neurologic injury or head injury. You know, we always think sports, but there are many 00:31:34.820 |
people who make a living in a way that is, um, over time is detrimental to their brain. What do you 00:31:42.420 |
think is the potential for these compounds, particular psilocybin, but other compounds as well for the, um, 00:31:48.820 |
treatment and possible even reversal of neurological injuries? There are anecdotes of, of people saying, 00:31:56.580 |
uh, that, that psychedelics have helped heal their brain. You know, they've been in one of these 00:32:03.860 |
situations like in sports, uh, a sport where there's repetitive head impact and they're claiming that, 00:32:10.180 |
you know, using psychedelics has actually improved their cognitive function. For example, improved their 00:32:15.860 |
memory. If you take these anecdotes and you combine it way across orders of analysis to the rodent research 00:32:22.980 |
from, um, several labs like David Olson, Brian, uh, Roth, these folks that have shown different forms of 00:32:29.780 |
neuroplasticity unfolding. Those effects may be at play and they improve in the psychiatric treatments 00:32:38.500 |
that we're dealing with that hat. We don't know that it seems like a decent guess. And we're going 00:32:42.980 |
to be figuring out whether that's the case, but another potential that that sets up is that maybe 00:32:48.260 |
that's what's going on with, um, with, um, with, with, with, with these claims of improvements from 00:32:56.020 |
neurological issues that there's actually, you know, uh, a repair of the brain, uh, uh, from injuries, 00:33:06.420 |
underlying, you know, things that, you know, situations where there's repetitive head impact, 00:33:11.140 |
perhaps there's a potential for, for helping folks recover from stroke, um, and disorders like that. 00:33:17.620 |
Um, it is more exploratory, but what I'm hoping to do is some work with retired athletes who have been 00:33:24.260 |
exposed, but by the nature of their sport, for example, in an a athletes in the UFC who have been 00:33:29.940 |
exposed to, um, repetitive head impacts, like a lot of sports, um, a lot of, uh, you know, sports expose 00:33:36.580 |
people to, and, and, and who are retired from the sport and are suffering from say depression, 00:33:42.100 |
which can, uh, in part result from those types of, of, of that history of head impact. 00:33:49.540 |
Um, see if we can fix the depression, but then also as a cherry on top in a more exploratory aim, 00:33:57.380 |
see if we can have evidence of, of improvement in cognitive function and associate like using MRI, 00:34:04.500 |
see if it affects gray matter over time, these types of things to see if there are actually some 00:34:08.980 |
evidence of this improved, um, like this more direct repair of the brain. But again, it is very 00:34:16.740 |
sort of like, we've got some rodent data, we've got some human anecdotes. We, we, we will acknowledge 00:34:23.780 |
it's early days and we look forward to seeing the data. Um, I, I appreciate how cautious you are 00:34:30.020 |
and tentative you are. You're not drawing any conclusions. Thank you so much for your time. 00:34:34.260 |
Thank you for your time, for your knowledge. And I think you put it best earlier for, uh, holding 00:34:38.580 |
the candle in a very dark time. And then now there's light.